L&C Bio Co PEG

Co robi L&C Bio Co? L&C Bio Co Ltd is a South Korean biotechnology company based in Seongnam, Gyeonggi-Do. The company went public on November 1, 2018, as indicated by its IPO date. It operates within the healthcare sector, specifically in the biotechnology industry. L&C Bio Co Ltd focuses on the development and commercialization of soft tissue allografts and medical devices. The company manufactures and sells human tissue transplant materials designed for tissue repair and filler applications. Additionally, it produces human tissue-based medical devices and cosmeceuticals. Its products are utilized across various medical fields, including vascular surgery, plastic surgery, and general surgery. The company's website is http://www.lncbio.co.kr/. L&C Bio Co Ltd is listed on the Korean stock market with the ticker symbol 290650.KQ and ISIN code KR7290650001. The company's primary business activities revolve around the production and distribution of tissue-based medical solutions, targeting both clinical and cosmetic applications. No additional details regarding founding year, key personnel, acquisitions, or specific product names beyond those mentioned are provided in the available information. L&C Bio Co jest jedną z najpopularniejszych firm na Eulerpool.